STM publisher Springer has launched a new open access journal Clinical Phytoscience. The international, open access journal will publish high-quality research articles on clinical evidence and use of medicinal plants in the development of efficient and well-tolerated phytotherapy. As part of SpringerOpen, all articles will be free to view and will appear also on SpringerLink.
Clinical Phytoscience focuses on phytotherapy, looking at proof of concept, efficacy and safety, comparable to pharmacotherapy. The journal will publish high-quality peer-reviewed evidence-based clinical studies and relevant pharmacological studies. The scientific results published in the journal should contribute to the recovery and maintenance of human health by phytotherapy.
Clinical Phytoscience is intended for use by pharmacologists, and medical doctors in clinic and practice, but as an open access journal, it will be freely accessible online to anyone, anywhere. Sponsored by the Phytoneering Foundation, there will be no article processing charges (APCs) for at least the first four years.
Editor-in-Chief Claus Bachert will lead an international editorial board of experts from the most important areas of phytotherapy. They are dedicated to ensuring that high-quality articles are published in this journal.
